Leukaemia during podophyllotoxin treatment in a patient with juvenile chronic arthritis.
Kauppi
M
M
Savolainen
H A
HA
Anttila
V J
VJ
Isomäki
H A
HA
D000208:Acute Disease; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D006027:Glycosides / Q000009:adverse effects*; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D017705:Lignans / Q000009:adverse effects*; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D011034:Podophyllotoxin / Q000009:adverse effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; C059428:CPH 82; D006027:Glycosides; D017705:Lignans; D011034:Podophyllotoxin